Chemotherapy Induced Peripheral Neuropathy Clinical Trial

The Chemotherapy Induced Peripheral Neuropathy (CIPN) clinical trial aims to improve the quality of life of those who are living with the pain and symptoms of peripheral neuropathy as a direct result of chemotherapy.

Symptoms of peripheral neuropathy are felt in a patient’s hand and feet and include:

  • weakness
  • numbness
  • tingling sensations or ‘pins and needles’
  • pain.

The purpose of this research is to find out what treatments are helpful in reducing symptoms of peripheral neuropathy.

The trial is not currently recruiting participants, but if you or someone that you know experiences these symptoms we encourage you to register your interest to participate in future clinical trials by emailing

To participate you must be:

  • Over the age of 18
  • Completed chemotherapy treatment within the past 3 months to 5 years
  • Have symptoms in your fingers/hand and toes/feet.

Participation is confidential and has been approved by the QUT Research Ethics Office. Our researchers follow the QUT Code of Conduct for Research.